Athersys completes patient enrollment for Phase I study of MultiStem – Pharmaceutical Business Review
Athersys completes patient enrollment for Phase I study of MultiStemPharmaceutical Business ReviewAthersys, a biopharmaceutical company, has completed patient enrollment for its Phase I study of MultiStem for Hematopoietic Stem Cell Transplant Support …